The Israeli startup builds an on-ramp for bringing security into the developer and DevOps workflow and ensure that product security is there from day zero
/PRNewswire/ Avenge Bio, Inc., a biotechnology company developing the LOCOcyte™ immunotherapy platform for the precision administration of potent immune.
Molecular test requirements will end for fully vaccinated Canadians returning from the United States by land border crossing, but questions remain as to how long the new rules will last, given the rise of a new COVID-19 variant.